{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T12:32:17Z","timestamp":1753360337347,"version":"3.41.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ucl.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T20:59:56Z","timestamp":1740603596000},"page":"193-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary Hypercortisolism"],"prefix":"10.1016","volume":"52","author":[{"given":"Carlo Andrea","family":"Bravi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2025.01.002_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ucl.2025.01.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101521","article-title":"Epidemiology and mortality of Cushing\u2019s syndrome","volume":"35","author":"Hakami","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.ucl.2025.01.002_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2010.03794.x","article-title":"Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects","volume":"73","author":"Morelli","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib4","doi-asserted-by":"crossref","first-page":"R567","DOI":"10.1530\/ERC-19-0240","article-title":"Diagnosis and management of primary bilateral macronodular adrenal hyperplasia","volume":"26","author":"Vassiliadi","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ucl.2025.01.002_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1356870","article-title":"The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review","volume":"15","author":"Sun","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1435102","article-title":"Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma","volume":"15","author":"Weng","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ecl.2018.02.007","article-title":"Genetics of Cushing\u2019s syndrome","volume":"47","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ucl.2025.01.002_bib8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/js.2018-00382","article-title":"Adrenal hypercortisolism: a closer look at screening, diagnosis, and important considerations of different testing modalities","volume":"3","author":"Chiodini","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ucl.2025.01.002_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing\u2019s syndrome: controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ucl.2025.01.002_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/a-0809-3647","article-title":"Hypercortisolism in newly diagnosed type 2 diabetes: a prospective study of 384 newly diagnosed patients","volume":"51","author":"Steffensen","year":"2019","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ucl.2025.01.002_bib12","doi-asserted-by":"crossref","first-page":"R247","DOI":"10.1530\/EJE-16-0434","article-title":"Diagnosis of endocrine disease: prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis","volume":"175","author":"Steffensen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.ucl.2025.01.002_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","article-title":"Pathophysiology of dyslipidemia in Cushing\u2019s syndrome","volume":"92","author":"Arnaldi","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ucl.2025.01.002_bib14","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1530\/EJE-20-1309","article-title":"Management of endocrine disease: cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing\u2019s syndrome: a practical approach","volume":"184","author":"Varlamov","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archinte.1981.00340020077021","article-title":"Neuropsychiatric manifestations of patients with Cushing\u2019s syndrome: relationship to cortisol and adrenocorticotropic hormone levels","volume":"141","author":"Starkman","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ucl.2025.01.002_bib16","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1530\/EJE-16-0289","article-title":"Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review","volume":"175","author":"Chiodini","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","article-title":"The immune system in Cushing\u2019s syndrome","volume":"31","author":"Hasenmajer","year":"2020","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.ucl.2025.01.002_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing\u2019s syndrome: a systematic meta-analysis","volume":"9","author":"Wagner","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101496","article-title":"Hypercoagulability in Cushing\u2019s syndrome: from arterial to venous disease","volume":"35","author":"St-Jean","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.ucl.2025.01.002_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.23143","article-title":"Subclinical Cushing\u2019s syndrome","volume":"106","author":"Tsinberg","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ucl.2025.01.002_bib21","doi-asserted-by":"crossref","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing\u2019s syndrome: update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib23","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/clinem\/dgac492","article-title":"Approach to the patient: diagnosis of cushing syndrome","volume":"107","author":"Savas","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ucl.2025.01.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101519","article-title":"Biochemical diagnosis of Cushing\u2019s disease: screening and confirmatory testing","volume":"35","author":"Petersenn","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.ucl.2025.01.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1028804","article-title":"The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism","volume":"13","author":"Berndt","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ucl.2025.01.002_bib26","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1210\/jc.2003-031790","article-title":"Midnight salivary cortisol for the initial diagnosis of Cushing\u2019s syndrome of various causes","volume":"89","author":"Yaneva","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ucl.2025.01.002_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1148\/rg.242035092","article-title":"CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome","volume":"24","author":"Rockall","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.ucl.2025.01.002_bib28","doi-asserted-by":"crossref","DOI":"10.4158\/EP12136.CR","article-title":"Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling","volume":"18","author":"Martins","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ucl.2025.01.002_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13081415","article-title":"Pitfalls in the diagnosis and management of hypercortisolism (cushing syndrome) in humans; A review of the laboratory medicine perspective","volume":"13","author":"Flowers","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.ucl.2025.01.002_bib30","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.eprac.2021.07.014","article-title":"When to suspect hidden hypercortisolism in type 2 diabetes: a meta-analysis","volume":"27","author":"Aresta","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ucl.2025.01.002_bib31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s40618-020-01484-2","article-title":"Hidden hypercortisolism: a too frequently neglected clinical condition","volume":"44","author":"Giovanelli","year":"2021","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.ucl.2025.01.002_bib32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamasurg.2020.3280","article-title":"Evaluation and treatment of patients with hypercortisolism: a review","volume":"155","author":"Miller","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ucl.2025.01.002_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.21037\/gs.2019.12.13","article-title":"Surgical approach to patients with hypercortisolism","volume":"9","author":"Kiernan","year":"2020","journal-title":"Gland Surg"},{"key":"10.1016\/j.ucl.2025.01.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101381","article-title":"Cushing\u2019s syndrome: treatment and new therapeutic approaches","volume":"34","author":"Ferriere","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.ucl.2025.01.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2023.102908","article-title":"Pharmacological treatment of Cushing\u2019s syndrome","volume":"54","author":"Castinetti","year":"2023","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ucl.2025.01.002_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101487","article-title":"Medical therapy in severe hypercortisolism","volume":"35","author":"Marques","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.ucl.2025.01.002_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101380","article-title":"Cushing\u2019s syndrome: overview of clinical presentation, diagnostic tools and complications","volume":"34","author":"Barbot","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.ucl.2025.01.002_bib38","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T18:33:59Z","timestamp":1750185239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014325000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0094014325000023"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2025.01.002","relation":{},"ISSN":["0094-0143"],"issn-type":[{"type":"print","value":"0094-0143"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Hypercortisolism","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}